Stock A358570 GI INNOVATION, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company GI Innovation, Inc.

Equities

A358570

KR7358570000

Biotechnology & Medical Research

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 18/06/2024 BST 		5-day change 1st Jan Change
10,330 KRW +0.88% Intraday chart for GI Innovation, Inc. -7.35% -14.27%
2023 GI Innovation, Inc.(KOSDAQ:A358570) added to S&P Global BMI Index CI
2023 GI Innovation, Inc. has completed an IPO in the amount of KRW 26 billion. CI

Business Summary

GI Innovation Inc is a Korea-based company engaged in the research and development of next-generation immunotherapies based on fusion proteins. The Company is engaged in the business of generating revenue through license fees by technology transfer of new drug candidates in pre-clinical and early clinical stages. The core new drug pipeline includes products such as GI-101 immuno-oncology and GI-301 allergy treatment.

Sales per Business

KRW in Million2022Weight2023Weight Delta
New Drug Development
100.0 %
3,500 100.0 % 5,319 100.0 % +51.97%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
100.0 %
3,500 100.0 % 5,319 100.0 % +51.97%

Managers

Managers TitleAgeSince
Jun-Ho Hong CEO
 Chief Executive Officer 52 15/06/21
Byeong-Geon Lee CEO
 Chief Executive Officer 67 03/03/22
Myung-Ho Jang PSD
 President 56 30/06/17
Young-Kyu Cho CTO
 Chief Tech/Sci/R&D Officer 55 31/08/19
Eun-Hee Rho IRC
 Investor Relations Contact 43 31/07/20
Eun-Sung Kim HRO
 Human Resources Officer 44 31/05/21

Members of the board

Members of the board TitleAgeSince
Byeong-Geon Lee CEO
 Chief Executive Officer 67 03/03/22
Geun-Yong An BRD
 Director/Board Member 49 02/03/22
Jun-Ho Hong CEO
 Chief Executive Officer 52 15/06/21
Myung-Ho Jang PSD
 President 56 30/06/17
Byung-Chul Kim BRD
 Director/Board Member 44 04/10/20
Hyun-Chul Kim BRD
 Director/Board Member 62 28/02/22
Yang-Ji Ryu BRD
 Director/Board Member 56 31/08/22

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 44,196,824 39,241,812 ( 88.79 %) 3,000 ( 0.006788 %) 88.79 %

Shareholders

NameEquities%Valuation
Myung-Ho Jang
6.912 %
3,054,806 6.912 % 26 M ₩
Dok-soo Jang
6.352 %
2,807,494 6.352 % 24 M ₩
Aju IB Investment Co., Ltd. (Private Equity)
5.323 %
2,352,484 5.323 % 20 M ₩
NH Investment & Securities Co., Ltd. /Private Equity/
4.375 %
1,933,700 4.375 % 16 M ₩
YUHAN CORPORATION
3.543 %
1,566,060 3.543 % 13 M ₩
Jae-hyun Kwon
3.394 %
1,500,082 3.394 % 13 M ₩
Su-Yeon Nam
2.795 %
1,235,122 2.795 % 10 M ₩
IMARKETKOREA INC.
2.743 %
1,212,120 2.743 % 10 M ₩
Kclavis Investment Co. Ltd.
2.473 %
1,092,808 2.473 % 9 M ₩
Hye-sung Lim
2.130 %
941,558 2.130 % 8 M ₩

Holdings

NameEquities%Valuation
GI INNOVATION, INC.
0.01%
 6,000 0.01% 50,312 $

Company contact information

GI Innovation, Inc.

167 Songpa-daero Songpa-gu

05855, Seoul

+

http://www.gi-innovation.com
address GI Innovation, Inc.(A358570)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Annual profits - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
GI INNOVATION, INC. Stock GI Innovation, Inc.
-14.27% 328M
MODERNA, INC. Stock Moderna, Inc.
+34.01% 51.07B
LONZA GROUP AG Stock Lonza Group AG
+33.84% 38.86B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-8.02% 38.78B
CELLTRION, INC. Stock Celltrion, Inc.
-8.98% 26.69B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+12.56% 26.35B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-19.62% 19.46B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+39.18% 13.58B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+31.47% 12.46B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
-3.40% 11.75B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. A358570 Stock
  4. Company GI Innovation, Inc.